Tabriz, Iran

Naser Namdar Habashi

This inventor holds 5 USPTO granted patents and 5 published patent applications. Top assignees: Nano Hesgarsazan Salamat Arya Incubation Center for Medical Equipment and Devices, Other. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naser Namdar Habashi. Retrieved from https://idiyas.com/inventor/naser-namdar-habashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Naser Namdar Habashi: Pioneering Innovations in Cancer Detection

Introduction:

In the realm of medical advancements, the name Naser Namdar Habashi stands tall as a prominent inventor and visionary. With a location in Tabriz, IR, Habashi has made remarkable contributions to the field of biomedical engineering, particularly in the development of non-invasive cancer detection methods. This article delves into his latest patents, career highlights, collaborations, and sheds light on his valuable contributions to the medical device industry.

Latest Patents:

Habashi's recent patents demonstrate his commitment to revolutionizing cancer detection. One notable invention is a real-time and label-free analyzer for in-vitro and in-vivo detecting suspicious regions associated with cancer. This novel method employs a probe incorporating two reference electrodes, a working electrode, and a counter electrode. By analyzing the cyclic voltammetry (CV) response of hypoxia-related hydrogen peroxide (HO) release, this invention enables the accurate detection of cancerous tumors within a patient's body. This breakthrough technique holds immense potential in revolutionizing early cancer diagnosis and improving patient outcomes.

Another significant patent of Habashi is an electrochemical probe apparatus designed for in-vivo measuring of HO oxidation within living tissue. This instrument features a biocompatible sensing part comprising a working electrode, a counter electrode, and a reference electrode. By utilizing a layer of vertically aligned multi-walled carbon nanotubes, the probe ensures precise and reliable electrochemical measurements. This invention paves the way for more accurate assessments of tissue health and enables timely interventions for various medical conditions, including cancer.

Career Highlights:

Throughout his career, Habashi has made remarkable strides in the medical device industry. He has worked with prestigious companies such as Nano Hesgarsazan Salamat Arya Incubation Center for Medical Equipment and Devices, where he has showcased unparalleled expertise in developing cutting-edge technologies for healthcare. Habashi's inventions have been a catalyst for advancements in cancer research, detection, and treatment methodologies, further cementing his status as a leading innovator in the field.

Collaborations:

Habashi's collaborations have been instrumental in his journey of innovation. He has collaborated with talented individuals who have contributed significantly to his groundbreaking inventions. Among his notable coworkers are Mohammad Abdolahad and Zohreh Sadat Miripour. These collaborations have undoubtedly fostered an environment of knowledge exchange and synergistic innovation, leading to the development of revolutionary solutions in cancer detection.

Conclusion:

Naser Namdar Habashi's contributions to the field of biomedical engineering, particularly in the domain of cancer detection, are truly remarkable. With his recent patents on non-invasive cancer detection methods and his involvement with leading companies and talented coworkers, Habashi has solidified his place among the foremost innovators in the medical device industry. By pushing the boundaries of scientific research and development, Habashi's inventions promise a brighter future for early cancer diagnosis and improved patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…